min chi lu - Infectious Diseases

Author Information

Min-Chi Lu is affiliated with the Division of Infectious Diseases, Department of Internal Medicine at China Medical University Hospital in Taichung, Taiwan. Additionally, Min-Chi Lu is part of the Department of Microbiology and Immunology at the School of Medicine, China Medical University, Taichung, Taiwan. The affiliation reflects a strong academic and clinical background in infectious diseases and microbiology.

Research Contributions

Min-Chi Lu has made significant contributions to the field of infectious diseases, with a particular focus on antimicrobial resistance and epidemiology. The research work involves nationwide surveillance studies on antimicrobial susceptibilities and resistance mechanisms among various pathogens, including Gram-negative bacteria and Streptococcus pneumoniae. Min-Chi Lu has also explored the immunogenicity and safety of COVID-19 vaccinations and has been involved in studies related to invasive infections and their clinical implications, such as Candida infections in critically ill surgical patients and the role of pathogens in colorectal tumorigenesis.

Aliases

Min-Chi Lu is also known by the aliases "M-c Lu" and "Min Lu" in various academic publications.

Publication and Citation Metrics

Metric	Value
Citation Count	2020
h-index	25
Paper Count	99

Publications:

Immunogenicity and safety of homologous and heterologous ChAdOx1-S and mRNA-1273 vaccinations in healthy adults in Taiwan

DOI: 10.1016/j.jcv.2022.105156

Year: 2022

Non-susceptibilities to antibiotics against important Gram-negative bacteria, and imipenem-relebactam, meropenem-vaborbactam against carbapenem non-susceptible Enterobacterales and Pseudomonas aeruginosa isolates implicated in complicated intra-abdominal and urinary tract infections in Taiwan, 2019.

DOI: 10.1016/j.ijantimicag.2022.106521

Year: 2022

Risk Factors and Prognoses of Invasive Candida Infection in Surgical Critical ill Patients with Perforated Peptic Ulcer

DOI: 10.1016/j.jmii.2022.03.001

Year: 2022

Multicenter surveillance of antimicrobial susceptibilities and resistance mechanisms among Enterobacterales species and non-fermenting Gram-negative bacteria from different infection sources in Taiwan from 2016 to 2018.

DOI: 10.1016/j.jmii.2021.07.015

Year: 2021

Respiratory care for the critical patients with 2019 novel coronavirus

DOI: 10.1016/j.rmed.2021.106516

Year: 2021

Genome analysis of Enterobacter hormaechei identified ISEcp1 in association with blaCTX-M-236, a new blaCTX-M variant located in both chromosome and plasmid.

DOI: 10.1016/j.jgar.2021.02.026

Year: 2021

Nationwide surveillance of antimicrobial resistance in invasive isolates of Streptococcus pneumoniae in Taiwan from 2017 to 2019.

DOI: 10.1016/j.jmii.2021.05.008

Year: 2021

National surveillance of antimicrobial susceptibilities to dalbavancin, telavancin, tedizolid, eravacycline, omadacycline and other comparator antibiotics and serotype distribution of invasive Streptococcus pneumoniae isolates in adults: results from the Surveillance of Multicenter Antimicrobial Res

DOI: 10.1016/j.jgar.2021.07.005

Year: 2021

Antimicrobial stewardship capacity and manpower needs in the Asia Pacific.

DOI: 10.1016/j.jgar.2021.01.013

Year: 2021

Two ST11 Klebsiella pneumoniae strains exacerbate colorectal tumorigenesis in a colitis-associated mouse model

DOI: 10.1080/19490976.2021.1980348

Year: 2021

Are Some Environments More Conducive to the Spread of Respiratory Droplets?

What Role Does the CDC Play in Infectious Diseases?

How to Choose the Right Insect Repellent?

How Common is Asymptomatic Infection?

What are Isoprenoids?

How is Co-Infection Diagnosed?

What are the Phases of the Inflammatory Response?

What is Viral Mutation and Why is it Important?

Why are Genomic Studies Important in Infectious Diseases?

How is Gonorrhea Diagnosed?

Partnered Content Networks

Relevant Topics